Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.
Smith E, Gasperetti A, Carrick RT, Protonotarios A, Syrris P, Bauce B, Pilichou K, Murray B, Tichnell C, Basso C, Olsen PAS, Cappelletto C, Parikh VN, Chen L, Peters S, Mancinelli A, Iorio AM, Scotto R, Cadrin-Tourigny J, Gilotra NA, Iseppi M, Peretto G, Schiavone M, Abela M, Vargas D, Crescenzi C, Calò L, Ware J, Crotti L, Ciabatti M, Casella M, Apostu A, Jurcut R, Raineri C, Angelini F, Fernández-Sellers C, Zorio E, Yap SC, Cox MG, Salavati A, Te Riele A, Wilde A, Amin AS, van Tintelen P, Saguner AM, Duru F, Abrams D, Cerrone M, Graziosi M, Biagini E, Gimeno JR, Gandjbakhch E, Lakdawala N, Pieroni M, Merlo M, Sinagra G, Haugaa K, Arbelo E, Elliott PM, Taylor M, Mestroni L, Calkins H, James CA, Helms AS.
Smith E, et al.
medRxiv [Preprint]. 2025 Jun 23:2025.06.16.25329734. doi: 10.1101/2025.06.16.25329734.
medRxiv. 2025.
PMID: 40666337
Free PMC article.
Preprint.
Integration of these criteria into LVEF-based classification improved identification of composite arrhythmia/heart failure events (early: diagnostic criteria with LVEF 50%, HR 2.7, p=0.04; intermediate: LVEF 41-49%, HR 3.7, p=0.009; advanced: LVEF 40% HR 10.3, p<0.001). …
Integration of these criteria into LVEF-based classification improved identification of composite arrhythmia/heart failure events (ea …